Artikel: Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor.
2004 Band 104, Heft 9, Seite(n) 2873–2878
Abstract: We have established human B-lineage (BLIN) acute lymphoblastic leukemia cell lines that retain a dependency on fibroblast monolayers for survival and proliferation. Eight hours following removal from adherent cell contact BLIN cells undergo a decrease in ...
Abstract | We have established human B-lineage (BLIN) acute lymphoblastic leukemia cell lines that retain a dependency on fibroblast monolayers for survival and proliferation. Eight hours following removal from adherent cell contact BLIN cells undergo a decrease in mitochondrial transmembrane potential and an increase in annexin V binding. Unexpectedly, the caspase-9 inhibitor (C9i) benzyloxycarbonyl-Leu-Glu-His-Asp-fluoromethylketone enhanced the appearance of apoptotic cells within 8 hours following removal of BLIN cells from fibroblast monolayers. C9i enhancement of apoptosis was dose dependent and did not occur with irreversible inhibitors of caspases-2, -3, -6, and -8. C9i also enhanced apoptosis in cord blood-derived CD19(+) B-lineage cells (but not myeloid cells) removed from murine stromal cells. Longer exposure (> 18 hours) to C9i culminated in apoptosis in a panel of B-lineage acute lymphoblastic leukemia (ALL) cell lines in the presence or absence of fibroblast monolayers, as well as in 2 proliferating leukemic cell lines (RAMOS and CEM). BLIN-4L cells made deficient in caspase-9 by RNA interference exhibited no resistance to apoptotic signals and actually showed increased apoptotic sensitivity to staurosporine. These collective results suggest that a 4-amino acid caspase inhibitor of caspase-9 can promote apoptosis and that at least some types of apoptotic pathways in B-lineage ALL do not require caspase-9. |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mesh-Begriff(e) | Animals ; Apoptosis/drug effects ; B-Lymphocytes/drug effects ; B-Lymphocytes/pathology ; Burkitt Lymphoma/pathology ; Caspase 9 ; Caspase Inhibitors ; Cell Line, Tumor ; Coculture Techniques ; Cysteine Proteinase Inhibitors/pharmacology ; Fibroblasts/cytology ; Hematopoietic Stem Cells/cytology ; Hematopoietic Stem Cells/drug effects ; Humans ; Mice ; Oligopeptides/pharmacology ; Stress, Physiological/pathology | ||||||||||
Chemische Substanzen | Caspase Inhibitors ; Cysteine Proteinase Inhibitors ; Oligopeptides ; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone ; CASP9 protein, human (EC 3.4.22.-) ; Casp9 protein, mouse (EC 3.4.22.-) ; Caspase 9 (EC 3.4.22.-) | ||||||||||
Sprache | Englisch | ||||||||||
Erscheinungsdatum | 2004-07-08 | ||||||||||
Erscheinungsland | United States | ||||||||||
Dokumenttyp | Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. | ||||||||||
ZDB-ID | 80069-7 | ||||||||||
ISSN | 1528-0020 ; 0006-4971 | ||||||||||
ISSN (online) | 1528-0020 | ||||||||||
ISSN | 0006-4971 | ||||||||||
DOI | 10.1182/blood-2003-10-3720 | ||||||||||
Signatur |
|
||||||||||
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Uh III Zs.140: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 364: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.